110 related articles for article (PubMed ID: 17074660)
21. Head and neck squamous cell carcinoma (HNSCC)--detection of synchronous primaries with (18)F-FDG-PET/CT.
Strobel K; Haerle SK; Stoeckli SJ; Schrank M; Soyka JD; Veit-Haibach P; Hany TF
Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):919-27. PubMed ID: 19205699
[TBL] [Abstract][Full Text] [Related]
22. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.
Kitagawa Y; Sano K; Nishizawa S; Nakamura M; Ogasawara T; Sadato N; Yonekura Y
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):63-71. PubMed ID: 12483411
[TBL] [Abstract][Full Text] [Related]
23. FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms.
Kitagawa Y; Sadato N; Azuma H; Ogasawara T; Yoshida M; Ishii Y; Yonekura Y
J Nucl Med; 1999 Jul; 40(7):1132-7. PubMed ID: 10405132
[TBL] [Abstract][Full Text] [Related]
24. [Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET)].
Di Martino E; Nowak B; Krombach GA; Sellhaus B; Hausmann R; Cremerius U; Büll U; Westhofen M
Laryngorhinootologie; 2000 Apr; 79(4):201-6. PubMed ID: 10838683
[TBL] [Abstract][Full Text] [Related]
25. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.
Murakami R; Uozumi H; Hirai T; Nishimura R; Shiraishi S; Ota K; Murakami D; Tomiguchi S; Oya N; Katsuragawa S; Yamashita Y
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):377-82. PubMed ID: 17321066
[TBL] [Abstract][Full Text] [Related]
26. Clinical impact of, and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma.
Connell CA; Corry J; Milner AD; Hogg A; Hicks RJ; Rischin D; Peters LJ
Head Neck; 2007 Nov; 29(11):986-95. PubMed ID: 17563906
[TBL] [Abstract][Full Text] [Related]
27. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
Fakhry N; Michel J; Colavolpe C; Varoquaux A; Dessi P; Giovanni A
Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
[TBL] [Abstract][Full Text] [Related]
28. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
[TBL] [Abstract][Full Text] [Related]
29. Unknown primary detected by FDG-PET. A review of the present indications of FDG-PET in head and neck cancers.
Sheikholeslam-zadeh R; Choufani G; Goldman S; Hassid S
Acta Otorhinolaryngol Belg; 2002; 56(1):77-82. PubMed ID: 11894635
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of intrathoracic lesions detected by 18F-fluorodeoxyglucose positron emission tomography in the management of patients with head and neck cancer.
Roh JL; Ryu CH; Kim JS; Lee JS; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Sep; 43(8):757-63. PubMed ID: 17112773
[TBL] [Abstract][Full Text] [Related]
31. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
Han A; Xue J; Hu M; Zheng J; Wang X
Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050
[TBL] [Abstract][Full Text] [Related]
32. FDG PET evaluation of head and neck cancer: value of imaging the thorax.
Keyes JW; Chen MY; Watson NE; Greven KM; McGuirt WF; Williams DW
Head Neck; 2000 Mar; 22(2):105-10. PubMed ID: 10679897
[TBL] [Abstract][Full Text] [Related]
33. [Role of PET-CT with 18-FDG in the management of UADT squamous-cell carcinomas: a retrospective study of 43 cases].
Ricard AS; Gindre A; Laurentjoye M; Fernandez P; Guyot M; Demeaux H; Siberchicot F; Majoufre-Lefebvre C
Rev Stomatol Chir Maxillofac; 2008 Apr; 109(2):86-90. PubMed ID: 18207477
[TBL] [Abstract][Full Text] [Related]
34. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion.
Schöder H; Yeung HW; Gonen M; Kraus D; Larson SM
Radiology; 2004 Apr; 231(1):65-72. PubMed ID: 14990824
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of recurrent squamous cell carcinoma of the head and neck with FDG positron emission tomography.
Li P; Zhuang H; Mozley PD; Denittis A; Yeh D; Machtay M; Smith R; Alavi A
Clin Nucl Med; 2001 Feb; 26(2):131-5. PubMed ID: 11201470
[TBL] [Abstract][Full Text] [Related]
36. Screening for distant metastases in patients with head and neck cancer: is there a role for (18)FDG-PET?
Brouwer J; Senft A; de Bree R; Comans EF; Golding RP; Castelijns JA; Hoekstra OS; Leemans CR
Oral Oncol; 2006 Mar; 42(3):275-80. PubMed ID: 16266820
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI.
Nowak B; Di Martino E; Jänicke S; Cremerius U; Adam G; Zimny M; Reinartz P; Büll U
Nuklearmedizin; 1999; 38(8):312-8. PubMed ID: 10615664
[TBL] [Abstract][Full Text] [Related]
38. Post-treatment surveillance of head and neck cancer: pitfalls in the interpretation of FDG PET-CT/MRI.
Meerwein CM; Queiroz M; Kollias S; Hüllner M; Veit-Haibach P; Huber GF
Swiss Med Wkly; 2015; 145():w14116. PubMed ID: 25701645
[TBL] [Abstract][Full Text] [Related]
39. What does PET imaging add to conventional staging of head and neck cancer patients?
Pohar S; Brown R; Newman N; Koniarczyk M; Hsu J; Feiglin D
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):383-7. PubMed ID: 17379443
[TBL] [Abstract][Full Text] [Related]
40. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
